-
公开(公告)号:US08013001B2
公开(公告)日:2011-09-06
申请号:US12337591
申请日:2008-12-17
申请人: Christopher D. Bayne , Alan T. Johnson , Shao Po Lu , Raju Mohan , Michael C. Nyman , Edwin J. Schweiger , William C. Stevens, Jr. , Haixia Wang , Yinong Xie
发明人: Christopher D. Bayne , Alan T. Johnson , Shao Po Lu , Raju Mohan , Michael C. Nyman , Edwin J. Schweiger , William C. Stevens, Jr. , Haixia Wang , Yinong Xie
IPC分类号: A61K31/4412 , C07D213/64
CPC分类号: C07D401/12 , C07D213/84 , C07D213/85 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/06 , C07D417/04 , C07D417/06 , C07D417/12
摘要: Compounds of the invention, such as compounds of formula (I): where n, m, A, B, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
摘要翻译: 本发明的化合物,例如式(I)的化合物:其中n,m,A,B,R 1,R 2,R 3,R 4和R 5在本文中定义,可用作肝X受体活性的调节剂。 还公开了含有化合物的药物组合物和使用该化合物的方法。
-
公开(公告)号:US20100056582A1
公开(公告)日:2010-03-04
申请号:US12337591
申请日:2008-12-17
申请人: Christopher D. Bayne , Alan T. Johnson , Shao-Po Lu , Raju Mohan , Michael C. Nyman , Edwin J. Schweiger , William C. Stevens, JR. , Haixia Wang , Yinong Xie
发明人: Christopher D. Bayne , Alan T. Johnson , Shao-Po Lu , Raju Mohan , Michael C. Nyman , Edwin J. Schweiger , William C. Stevens, JR. , Haixia Wang , Yinong Xie
IPC分类号: A61K31/4439 , C07D213/63 , C07D401/04 , A61K31/44
CPC分类号: C07D401/12 , C07D213/84 , C07D213/85 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/06 , C07D417/04 , C07D417/06 , C07D417/12
摘要: Compounds of the invention, such as compounds of formula (I): where n, m, A, B, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
摘要翻译: 本发明的化合物,例如式(I)的化合物:其中n,m,A,B,R 1,R 2,R 3,R 4和R 5在本文中定义,可用作肝X受体活性的调节剂。 还公开了含有化合物的药物组合物和使用该化合物的方法。
-
公开(公告)号:US20080119488A1
公开(公告)日:2008-05-22
申请号:US11572579
申请日:2005-07-24
申请人: Christopher D. Bayne , Alan T. Johnson , Shao-Po Lu , Raju Mohan , Michael C. Nyman , Edwin J. Schweiger , William C. Stevens , Haixia Wang , Yinong Xie , Lynne Canne Bannen , Diva Sze-Ming Chan , Ping Huang , Vasu Jammalamadaka , Richard G. Khoury , Morrison B. Mac , Jason Jevious Parks , Yong Wang , Wei Xu
发明人: Christopher D. Bayne , Alan T. Johnson , Shao-Po Lu , Raju Mohan , Michael C. Nyman , Edwin J. Schweiger , William C. Stevens , Haixia Wang , Yinong Xie , Lynne Canne Bannen , Diva Sze-Ming Chan , Ping Huang , Vasu Jammalamadaka , Richard G. Khoury , Morrison B. Mac , Jason Jevious Parks , Yong Wang , Wei Xu
IPC分类号: A61K31/497 , C07D211/98 , A61K31/4418 , C07D401/12 , A61K31/513 , C07D401/04 , A61K31/443 , A61P3/00 , A61P25/00 , C12N5/06 , C07K14/00 , A61P9/00 , A61P17/10 , A61K31/4433 , C07D401/14 , A61K31/4439 , A61K31/4545 , C07D409/04 , A61K31/4436
CPC分类号: C07D401/12 , C07D213/84 , C07D213/85 , C07D401/04 , C07D401/06 , C07D401/10 , C07D401/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/06 , C07D417/04 , C07D417/06 , C07D417/12
摘要: Compounds of the invention, such as compounds of formula (I), where n, m, A, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
摘要翻译: 本发明的化合物,例如式(I)化合物,其中n,m,A,R 1,R 2,R 3,R 4和R 5在本文中定义,可用作肝X受体活性的调节剂。 还公开了含有化合物的药物组合物和使用该化合物的方法。
-
4.Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands 审中-公开
标题翻译: 杂环羧酰胺化合物作为类固醇核受体配体公开(公告)号:US20110144128A1
公开(公告)日:2011-06-16
申请号:US11813482
申请日:2006-01-06
申请人: Brenton T. Flatt , Xiao-Hui Gu , Richard Martin , Raju Mohan , Brett Murphy , Michael C. Nyman , William C. Stevens, JR. , Tie-Lin Wang
发明人: Brenton T. Flatt , Xiao-Hui Gu , Richard Martin , Raju Mohan , Brett Murphy , Michael C. Nyman , William C. Stevens, JR. , Tie-Lin Wang
IPC分类号: A61K31/506 , A61K31/4439 , A61K31/4172 , C07D413/14
CPC分类号: C07D231/14 , C07D233/90 , C07D307/68 , C07D333/38
摘要: Heterocyclic carboxamide compounds are described herein as being useful in modulating the activity of steroid nuclear receptors. Pharmaceutical compositions containing the compounds, methods of using the compounds and processes for making the compounds are also described.
摘要翻译: 本文描述的杂环羧酰胺化合物可用于调节类固醇核受体的活性。 还描述了含有化合物的药物组合物,使用该化合物的方法和制备该化合物的方法。
-
-
-